Characterization of regulated cancer cell death pathways induced by the different modalities of non-thermal plasma

Eline Biscop1,2, Jana Baroen3,4, Joey De Backer5

  • 1PLASMANT, Department of Chemistry, University of Antwerp, Antwerp, Belgium. eline.biscop@uantwerpen.be.

Cell Death Discovery
|September 30, 2024
PubMed

Insights

Non-thermal plasma (NTP) triggers multiple cancer cell death pathways, including apoptosis and ferroptosis. Direct NTP uniquely induces pyroptosis, offering distinct therapeutic strategies for melanoma treatment.

Area of Science:

  • Biomedical Engineering
  • Cancer Biology
  • Plasma Medicine

Background:

  • Non-thermal plasma (NTP) demonstrates potential in anti-cancer therapies.
  • Limited understanding exists regarding NTP-induced regulated cell death (RCD) mechanisms and treatment modality differences.

Purpose of the Study:

  • To investigate apoptosis, pyroptosis, necroptosis, and ferroptosis in melanoma cells after NTP treatment.
  • To delineate molecular mechanistic differences between direct and indirect NTP modalities.

Main Methods:

  • Melanoma cells were treated with direct and indirect NTP.
  • Specific inhibitors for apoptosis, pyroptosis, necroptosis, and ferroptosis were used to identify triggered RCD pathways.
  • RCD-specific molecular markers (e.g., caspase activity, lipid peroxidation, annexin V) were analyzed.

Main Results:

  • Both direct and indirect NTP induced apoptosis (increased caspase 3/7, annexin V) and ferroptosis (increased lipid peroxidation).
  • Direct NTP uniquely triggered pyroptosis (increased caspase 1 activity).
  • Necroptosis was induced in a cell line-dependent manner.

Conclusions:

  • NTP activates multiple RCD pathways in melanoma cells, with distinct mechanisms for direct vs. indirect application.
  • Understanding these RCD pathways is crucial for developing effective NTP-based cancer therapies.
  • Targeting multiple pathways simultaneously via combination therapies can enhance therapeutic efficacy and overcome resistance.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K